Lista de obras -

A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer

artículo científico publicado en 2011

A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer

artículo científico publicado en 2014

A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer

artículo científico publicado en 2008

ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics

artículo científico publicado en 2015

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.

artículo científico publicado en 2008

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

artículo científico publicado en 2018

Axillary Dissection vs. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution Experience

scientific article published on 01 November 2019

B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression

artículo científico publicado en 2007

Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis

artículo científico publicado en 2015

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

artículo científico publicado en 2014

Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.

artículo científico publicado en 2015

Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells

artículo científico publicado en 2010

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

artículo científico publicado en 2015

Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14

artículo científico publicado en 2007

Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.

artículo científico publicado en 2009

Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.

artículo científico publicado en 2003

Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma

artículo científico publicado en 2003

Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome

artículo científico publicado en 2011

Functional role and prognostic significance of CD157 in ovarian carcinoma.

artículo científico publicado en 2010

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

artículo científico publicado en 2008

Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

artículo científico publicado en 2010

Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer

artículo científico publicado en 2013

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1

artículo científico publicado en 2008

Human tissue kallikreins: from gene structure to function and clinical applications

artículo científico publicado en 2005

IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics ⬇️

artículo científico publicado el 1 de enero de 2011

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

artículo científico publicado en 2003

KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer

scientific journal article

Lin-28 homologue A (LIN28A) promotes cell cycle progression via regulation of cyclin-dependent kinase 2 (CDK2), cyclin D1 (CCND1), and cell division cycle 25 homolog A (CDC25A) expression in cancer

artículo científico publicado en 2012

Netrin-1 overexpression is predictive of ovarian malignancies ⬇️

artículo científico publicado el 1 de mayo de 2011

Novel surface targets and serum biomarkers from the ovarian cancer vasculature ⬇️

artículo científico publicado el 1 de agosto de 2011

Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells

artículo científico publicado en 2004

PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer

artículo científico publicado en 2012

Parallel overexpression of seven kallikrein genes in ovarian cancer.

artículo científico publicado en 2003

Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics

artículo científico publicado en 2008

Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1 ⬇️

artículo científico publicado el 12 de agosto de 2011

Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer

artículo científico publicado en 2015

Prognostic value of the human kallikrein gene 15 expression in ovarian cancer

artículo científico publicado en 2003

Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvan

artículo científico publicado en 2005

Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome

artículo científico publicado en 2011

The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness

artículo científico publicado en 2003

The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer

artículo científico publicado en 2013

The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer

artículo científico publicado en 2004

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

artículo científico publicado en 2008

The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer

artículo científico publicado en 2012

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

artículo científico publicado en 2016

Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth.

artículo científico publicado en 2005

Transcriptional regulation of PIK3CA oncogene by NF-kappaB in ovarian cancer microenvironment

artículo científico publicado en 2008

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer

artículo científico publicado en 2003

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

artículo científico publicado en 2008

microRNAs exhibit high frequency genomic alterations in human cancer

artículo científico publicado en 2006

Lista de obras de

A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer

A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer

A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer

ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Axillary Dissection vs. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution Experience

B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression

Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.

Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14

Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.

Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.

Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma

Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome

Functional role and prognostic significance of CD157 in ovarian carcinoma.

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1

Human tissue kallikreins: from gene structure to function and clinical applications

IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics ⬇️

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer

Lin-28 homologue A (LIN28A) promotes cell cycle progression via regulation of cyclin-dependent kinase 2 (CDK2), cyclin D1 (CCND1), and cell division cycle 25 homolog A (CDC25A) expression in cancer

Netrin-1 overexpression is predictive of ovarian malignancies ⬇️

Novel surface targets and serum biomarkers from the ovarian cancer vasculature ⬇️

Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells

PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer

Parallel overexpression of seven kallikrein genes in ovarian cancer.

Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics

Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1 ⬇️

Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer

Prognostic value of the human kallikrein gene 15 expression in ovarian cancer

Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvan

Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome

The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness

The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer

The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth.

Transcriptional regulation of PIK3CA oncogene by NF-kappaB in ovarian cancer microenvironment

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

microRNAs exhibit high frequency genomic alterations in human cancer